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Abstract
Antiviral defense in the liver during acute infection with the hepatotropic virus murine cytomegalovirus (MCMV) involves
complex cytokine and cellular interactions. However, the mechanism of viral sensing in the liver that promotes these
cytokine and cellular responses has remained unclear. Studies here were undertaken to investigate the role of nucleic acid-
sensing Toll-like receptors (TLRs) in initiating antiviral immunity in the liver during infection with MCMV. We examined the
host response of UNC93B1 mutant mice, which do not signal properly through TLR3, TLR7 and TLR9, to acute MCMV
infection to determine whether liver antiviral defense depends on signaling through these molecules. Infection of UNC93B1
mutant mice revealed reduced production of systemic and liver proinflammatory cytokines including IFN-a, IFN-c, IL-12 and
TNF-a when compared to wild-type. UNC93B1 deficiency also contributed to a transient hepatitis later in acute infection,
evidenced by augmented liver pathology and elevated systemic alanine aminotransferase levels. Moreover, viral clearance
was impaired in UNC93B1 mutant mice, despite intact virus-specific CD8+ T cell responses in the liver. Altogether, these
results suggest a combined role for nucleic acid-sensing TLRs in promoting early liver antiviral defense during MCMV
infection.
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Introduction
Initiation of inflammation following infection requires recogni-
tion of the invading microbe by innate immune pattern
recognition receptors (PRRs) that signal in response to patho-
gen-associated molecular patterns (PAMPs). PRRs recognize self-
and microbe-associated molecules [1–4]. Members of the Toll-like
receptor (TLR) family of PRRs are transmembrane receptors that
are expressed either on the cell surface or within the endosomal
compartment and respond to a variety of PAMPs [1]. Murine
TLR3, TLR7 and TLR9 are expressed in the endolysosome and
are implicated in recognition of viral dsRNA, ssRNA and dsDNA,
respectively [1,5–11]. Ligation of the nucleic acid-sensing TLRs
results in transcription of antiviral genes including type I IFNs
(IFN-a/b) and proinflammatory cytokines [1]. TLR3 responses
require signaling through the adaptor molecule Toll/IL-1R
domain-containing adapter-inducing interferon-b (TRIF), while
TLR7 and TLR9 are dependent on the adaptor molecule myeloid
differentiation primary response gene 88 (MyD88) to activate
transcription factors and induce gene transcription [1,12–14].
Murine cytomegalovirus (MCMV) is a betaherpesvirus that can
establish acute infection in multiple organs including the liver.
Acute MCMV infection induces an early systemic proinflamma-
tory cytokine response including high levels of type I IFNs, IFN-c,
IL-12 and TNF-a [15–19]. Infection in the liver induces early
production of IFN-a, predominantly by plasmacytoid dendritic
cells (pDCs), by 40 h post-infection [20,21]. Type I IFN pro-
duction mediates downstream responses including chemokine and
cytokine production as well as monocyte/macrophage, natural
killer (NK) cell and T cell recruitment [20–23]. Early type I IFN
signaling is necessary for NK cell recruitment to the liver, where
they deliver the antiviral cytokine IFN-c within the first 48 h post-
MCMV infection [23]. The NK cell IFN-c response is an
important early step in the control of liver infection [24,25]. This
response induces IFN-c-dependent chemokines, which contribute
to the recruitment of CD8+ T cells to the liver [26]. Liver CD8+ T
cell responses occur by days 5 and 7 post-MCMV infection and
are an important source of cytokines late in acute infection that
contribute to resistance against MCMV [26–30].
While early responses to MCMV infection in the liver are well
understood, it remains unclear how the virus is sensed in this
compartment. This is in contrast with other sites, namely the
spleen, in which studies by our group and others have definitively
shown a role for TLR9 and MyD88 signaling in IFN-a,
proinflammatory cytokine and cellular responses in addition to
restriction of virus replication [6,20,31,32]. Although TLR7 alone
does not appear to have a strong role in MCMV recognition,
TLR7 and TLR9 combined deficiency was shown to severely
impair pDC responses against MCMV in the spleen [33]. A
significant but minor role for TLR3 signaling in the spleen has also
been suggested in response to MCMV infection [6]. In the liver,
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responses are TLR9-independent but MyD88-dependent [20].
Liver pDCs from mice genetically deficient in TLR9 produce
wild-type (WT) levels of IFN-a at 40 h post-MCMV infection,
with intact downstream cellular and proinflammatory cytokine
responses. Further, TLR9-deficient mice do not exhibit elevated
liver viral titers. Conversely, MyD88-deficient mice have severely
impaired liver cytokine and cellular responses, and are unable to
control virus replication in this compartment [20,32]. MyD88 is
a common adaptor molecule for TLR9 and TLR7 signaling;
however, evaluation of TLR7-deficient mice also demonstrated
that TLR7 signals alone were not required to initiate liver antiviral
defense [20].
These TLR-independent but MyD88-dependent antiviral
responses suggested possible redundancies among TLR signals in
the liver compartment in response to MCMV infection [20,32].
To investigate this possibility, we utilized mice containing an
H412R missense mutation in the endoplasmic reticulum protein
UNC93B1 to address the combined function of nucleic acid-
sensing TLRs in the liver during acute MCMV infection. The
UNC93B1 mutation (known as ‘triple d’ or ‘3d’) impairs signaling
through TLR3, TLR7 and TLR9 due to improper trafficking of
these receptors to the endosomal compartment, and has been
shown to affect exogenous antigen presentation [34,35]. Our
studies show that proinflammatory cytokine production after early
infection with MCMV is dependent on UNC93B1. Further,
UNC93B1 deficiency exacerbates liver disease and increases viral
burden, although MCMV-specific CD8+ T cell responses are not
impaired. Collectively, these results suggest a level of redundancy
within the liver to promote viral recognition by demonstrating that
a combination of nucleic acid-sensing TLRs contributes to innate
inflammatory responses during MCMV infection.
Results
Systemic cytokine production is impaired in 3d mice
during MCMV infection
Considering the potential of endosomal TLR signals to induce
proinflammatory cytokine expression, UNC93B1 deficient 3d
mice were first assessed for systemic IFN-a, IFN-c, IL-12 and
TNF-a production during early infection with a moderate
(5610
4 PFU) dose of MCMV. C57BL/6 (WT) and 3d mice were
uninfected or MCMV-infected for 40 h or 48 h. Serum was
collected at indicated time points and IFN-a, IFN-c, IL-12p70 and
TNF-a were measured by enzyme-linked immunosorbent assay
(ELISA). In WT mice, maximal production of IFN-a, IFN-c and
IL-12p70 was detected at 40 h post-MCMV infection before
declining by 48 h post-infection (Fig. 1, A–C). In contrast, 3d mice
Figure 1. Effect of the 3d mutation on systemic cytokine production during MCMV infection. C57BL/6 (WT) or 3d mice were either
uninfected or infected for 40 h or 48 h with MCMV. Serum was collected at indicated time points and tested for (A) IFN-a, (B) IFN-c, (C) IL-12p70 and
(D) TNF-a production by sandwich ELISA. Data are the combined results from two to three independent experiments and show the mean 6 SD
(n=3–10 mice per group for each time point tested). Asterisks denote p values#0.01.
doi:10.1371/journal.pone.0039161.g001
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MCMV infection. Specifically, while serum IFN-a reached
13006420 pg/mL at 40 h post-MCMV infection in WT mice,
IFN-a production was reduced by three-fold at this infection time
point in 3d mice (4506300 pg/mL), with comparable levels
maintained at 48 h post-infection (Fig. 1A). Likewise, while
average IFN-c concentrations in WT mice reached maximal
levels of 5306245 pg/mL at 40 h post-MCMV infection, 3d mice
failed to induce detectable levels of this cytokine (Fig. 1B). IL-
12p70 production similarly peaked at 40 h post-MCMV infection
in WT mice, with levels reaching 10006600 pg/mL. 3d mice,
however, produced 12-fold less IL-12p70 at this infection time
point (Fig. 1C). Serum TNF-a levels were elevated in response to
MCMV infection at both 40 h and 48 h post-infection in WT
mice (69610 and 63617 pg/mL, respectively, Fig. 1D). In 3d
mice, average concentrations of TNF-a were 6-fold lower than
WT at 40 h and 2.5-fold lower than WT at 48 h after infection.
These results indicate a requirement for endosomal TLR signals
for early systemic proinflammatory cytokine production, and
concur with previous reports [35].
Liver cytokine production is impaired in MCMV-infected
3d mice
Having observed a reduction in the level of proinflammatory
cytokines in the serum of 3d mice, cytokine responses in liver cells
from 3d mice infected with MCMV were evaluated to address the
impact of endosomal TLR signaling in a localized tissue site of
infection. The best characterized liver cytokine responses are IFN-
a and IFN-c [20,21,36]. Therefore, to determine whether
combined endosomal TLR signaling contributes to the production
of these cytokines during MCMV infection, IFN-a and IFN-c in
liver homogenates and in individual cell populations were
measured in WT and 3d mice uninfected or infected with MCMV
for 40 h and 48 h. As shown in Fig. 2A, WT mice displayed four-
fold higher levels of IFN-a than 3d mice at 40 h post-infection,
with increased levels still evident at 48 h following infection. Since
pDCs expressing the marker PDCA-1 have been shown to
produce the majority of liver IFN-a at 40 h post-MCMV infection
[20], this cell type was examined in WT and 3d livers during early
infection. There was evidence of pDC accumulation in the livers of
both WT and 3d mice (Fig. 2B). However, liver pDCs from 3d
mice were impaired in their ability to express IFN-a. There were
4-fold fewer PDCA-1+ pDCs expressing intracellular IFN-a at
40 h, and 3-fold fewer at 48 h post-infection, in 3d mice as
compared to WT (Fig. 2C). This trend was also reflected in the
proportion of PDCA-1+ IFN-a+ pDCs at 40 h and 48 h after
infection in 3d mice (0.8%60.4% and 2%61%) compared with
WT (2%61% and 6%61%).
3d mice similarly demonstrated a defect in liver IFN-c
production in response to MCMV infection. In WT mice, IFN-c
reached maximal levels of 350061200 pg/g liver at 40 h before
contracting by approximately half at 48 h post-infection. In
contrast, at 40 h post-infection, 3d mice induced 5-fold less IFN-c
than WT (Fig. 2D). NK cells are an important early source of IFN-
c in the liver during MCMV infection [24,25], and accumulated at
this site in both WT and 3d mice (Fig. 2E). Using intracellular
cytokine staining, results shown in Fig. 2F demonstrate a 7-fold
reduction in the absolute numbers of NK1.1+ TCRb- liver cells
expressing IFN-c in 3d mice at 40 h post-infection as compared to
WT. There were also fewer IFN-c-expressing liver NK cells in 3d
mice by proportion (0.8%60.3% and 1%60.4%) when compared
to WT (6%62% and 4%60.4%) at 40 h and 48 h, respectively.
Together, these results demonstrate that, in addition to an effect
on systemic cytokine production, combined endosomal TLR
signals can affect the expression of critical proinflammatory
cytokines in the liver during MCMV infection.
Liver T cell responses are not impaired in 3d mice during
MCMV infection
The innate immune response is important both in establishing
early control of virus replication and in coordinating downstream
adaptive responses. Following MCMV infection, virus-specific
CD8+ T cells are recruited to the liver within 5 days and control
viral replication at this site through release of cytotoxic molecules
and production of cytokines such as IFN-c and TNF-a [26,27].
Given the abated liver cytokine responses observed in 3d mice, the
effect of endosomal TLR signaling on liver CD8+ T cell responses
was examined at late time points during acute MCMV infection.
The results shown in Fig. 3A demonstrate comparable absolute
numbers of CD8+ T cells in WT and 3d mice at days 5 and 7 post-
MCMV infection, a trend that was also reflected in proportion
(data not shown). To determine whether CD8+ T cells in 3d mice
were properly activated against MCMV infection, intracellular
expression of IFN-c and TNF-a in CD8+ T cells was examined
following ex vivo restimulation with H-2D
b M45 viral peptide, an
immunodominant epitope of MCMV [29]. CD8+ T cells from 3d
mice expressed these two cytokines at day 5 and day 7 post-
MCMV infection by proportion and absolute numbers at levels
that were comparable or slightly increased over WT (Fig. 3, B–E).
As an indication of degranulation, surface expression of CD107a
was also examined on liver CD8+ T cells from mice infected with
MCMV; however, no differences in CD107a expression were
detected between 3d and WT mice (data not shown). These results
suggest that MCMV-specific CD8+ T cell responses in the liver
are not compromised in the absence of endosomal TLR signals.
Increased sensitivity to virus-induced liver disease in 3d
mice during MCMV infection
Previous studies have demonstrated resolution of virus-induced
liver disease after 5 days of MCMV infection in WT mice
[22,24,27,37]. Therefore, given the impaired inflammatory
responses observed in the absence of endosomal TLR signaling,
liver sections prepared from 3d and WT mice that were uninfected
or infected for 3, 5, or 7 days were hematoxylin and eosin (H&E)
stained to evaluate pathology. The histological appearance of liver
sections from uninfected 3d and WT mice appeared comparable
(Fig. 4, A and B). By day 3 post-MCMV infection, clusters of
infiltrating cells or inflammatory foci, which have been shown to
coincide with sites of MCMV antigen expression [23,37], were
present in WT mice and persisted through day 5 before
inflammation was resolved by day 7 post-infection (Table 1,
Fig. 4, C, E and G). While the inflammatory foci per area of liver
were equally apparent in liver sections from 3d mice infected for 3
days (Table 1), there was an increased presence of cytomegalic
inclusion bodies characteristic of MCMV-infected cells that were
not readily apparent in WT mice (Fig. 4D). By day 5 post-
infection, livers from 3d mice were characterized by widespread
areas of inflammation compared to the more punctate foci in WT
livers (Fig. 4, E and F). Moreover, the inflammatory foci per area
of liver in 3d mice at day 5 post-infection were significantly more
numerous and contained a greater number of nucleated cells
compared to WT (Table 1). However, by day 7 post-infection,
inflammation in 3d mice showed signs of resolution that were
similar to WT (Table 1, Fig. 4, G and H).
To further evaluate the effects of endosomal TLR responses on
overall liver function, the liver enzyme alanine aminotransferase
(ALT) was measured in serum samples from WT and 3d mice that
UNC93B1 Effects on Antiviral Immunity in Liver
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Uninfected mice had comparable baseline levels of systemic ALT
(Fig. 5). By day 3 of infection, similar elevations in ALT levels were
detected in both groups. In contrast, by day 5 post-infection, the
levels of systemic ALT in 3d mice reached values of 9006400 U/
L and were three-fold higher than the ALT levels measured in WT
mice (2706100 U/L; Fig. 5), indicating augmented liver disease.
In contrast, by day 7 post-infection, 3d mice demonstrated a sharp
decline in systemic ALT levels to values of 117663 U/L, which
were comparable to ALT levels exhibited in WT mice
(108685 U/L). Thus, at this time point of acute infection, both
groups of mice exhibited ALT levels near baseline levels,
consistent with the resolution of virus-induced liver pathology
observed in 3d and WT mice (Fig. 4, G and H; Fig. 5). Taken
together, these results suggest that in the absence of endosomal
TLR signals, there is pronounced liver inflammation accompanied
by a transient increase in liver damage during acute MCMV
infection.
Impairment of viral clearance in 3d mice
Given the diminished early cytokine responses and enhanced
liver disease observed in 3d mice, the contribution of endosomal
TLR responses to control of virus replication in the liver was
assessed in WT and 3d mice infected with MCMV. Compared
with those in WT mice, viral titers were elevated by 1 log on day 3
of infection in 3d mice, and remained significantly higher at day 5
post-infection when compared to WT (Fig. 6). Ultimately, while
WT livers showed evidence of viral clearance at days 7 and 9 post-
infection, 3d liver virus titers remained approximately 2 logs
higher at these times of infection as compared to WT mice. Thus,
endosomal TLR signaling contributes to the control of MCMV
replication in the liver during acute infection.
Discussion
The aim of these studies was to identify the TLR signaling
pathways required for the innate recognition of virus infection in
the liver, a common target organ of many viruses that significantly
contributes to innate immune defenses [38–40]. Moreover, the
liver contains various innate immune cells that express TLRs
[41,42]; however, the role of TLRs in host defense against
infection at this site remains largely unclear. Because responses in
the liver do not appear dependent on individual TLRs [6,20,32],
we utilized 3d mice, which lack endosomal TLR3, TLR7 and
TLR9 signaling due to a mutation in the endoplasmic reticulum-
resident protein UNC93B1 [34,35], to address the contribution of
endosomal TLRs in liver antiviral defenses against acute MCMV
infection. The results demonstrated impaired production of
Figure 2. Effect of the 3d mutation on liver cytokine production and innate effector cell accumulation during MCMV infection. (A
and D) Liver homogenates were generated from C57BL/6 (WT) or 3d mice that were either uninfected or infected for 40 h or 48 h with MCMV.
Concentration of (A) IFN-a and (D) IFN-c in liver homogenates was measured by sandwich ELISA. Data are the combined results from two
independent experiments and show the mean 6 SD (n=3–6 mice per group). (B, C, E, F) Liver leukocytes were prepared from C57BL/6 (WT) or 3d
mice that were either uninfected or infected with MCMV for 40 h or 48 h. Leukocytes were then stained for cell surface expression of PDCA-1 or
NK1.1 and TCRb, fixed, permeabilized, and stained for intracellular IFN-a or IFN-c, as described in Methods. Results show the total numbers of (B)
PDCA-1+, (C) IFN-a+ PDCA-1+, (E) NK1.1+ TCRb– and (F) IFN-c+ NK1.1+ TCRb– cells. Data are the combined results from 3–4 independent experiments
(B, E) or at least two independent experiments (C, F) and show the mean 6 SD (n=3–11 mice per group for each time point tested). Asterisks denote
p values#0.04.
doi:10.1371/journal.pone.0039161.g002
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e39161Figure 3. Effect of the 3d mutation on CD8+ T cell accumulation and MCMV-specific cytokine responses. Liver leukocytes were
prepared from C57BL/6 (WT) and 3d mice that were either uninfected or infected with MCMV for 5 or 7 days and analyzed by flow cytometry. (A) The
total numbers of CD8a+ TCRb+ cells per liver are shown. To quantitate intracellular expression of cytokines in activated CD8+ T cells, prepared liver
leukocytes were cultured with M45 viral peptide, and then harvested and stained for surface expression of CD8a and TCRb followed by intracellular
IFN-c or TNF-a as described in Methods. (B and C) Results show the proportion and total numbers of CD8a+ TCRb+ IFN-c+ and (D and E) CD8a+
TCRb+ TNF-a+ (D and E) cells. Data are representative of six independent experiments and show the mean 6 SD (n=3 mice per group). Asterisks
denote p values#0.02.
doi:10.1371/journal.pone.0039161.g003
Figure 4. Characterization of virus-induced liver disease in 3d mice. Livers were harvested from C57BL/6 (WT) (A, C, E, G) or 3d mice (B, D, F,
H) that were either uninfected (A and B) or infected for 3 (C and D), 5 (E and F) or 7 (G and H) days with MCMV (5610
4 PFU). Paraffin-embedded
blocks were sectioned, stained with H&E, and analyzed by microscopy. Images were digitally captured at the original magnification of610 or at620
(inset in D). Arrowheads in C and E indicate inflammatory foci; arrows and inset in D indicate cytomegalic inclusions; open arrowheads in F denote
areas of inflammation.
doi:10.1371/journal.pone.0039161.g004
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MCMV-infected 3d mice. Additionally, 3d mice had elevated viral
titers in the liver that coincided with transient but exacerbated
liver disease, although virus-specific CD8+ T cell responses were
not affected. Interestingly, a previous study demonstrated that
TLR3 was not required for the generation of adaptive antiviral
responses to MCMV [43], although there is evidence that TLR3
signaling contributes in part to the early control of MCMV
infection by the systemic induction of type I IFN [6]. Other studies
have implicated a synergistic role for TLR7 and TLR9 in
promoting MCMV recognition and immune defense in the spleen
[33]. The impaired liver responses observed in 3d mice that were
not apparent in TLR9 or TLR7-deficient mice [20] suggests that
a level of redundancy unique to innate immunity is in place within
infected tissue sites to rapidly respond to viral infection. Overall,
these studies advance our understanding of the process of viral
recognition in the complex liver environment and suggest that
UNC93B1 is a critical intermediate factor in innate virus sensing
activated by MCMV.
Previous studies have demonstrated impaired serum cytokine
production and increased susceptibility to infection in 3d mice
infected with a high lethal dose of MCMV [35]; however, our
study is the first report to document the contribution of the 3d
mutation to impaired MCMV defense in the liver. In agreement
with the study by Tabeta et al. [35], our results, using a moderate
dose of MCMV, demonstrated a diminished serum cytokine
response (Fig. 1), reduced splenic IFN-a production and elevated
viral titers in the spleen (data not shown). These results were not
unexpected given the known role for the nucleic acid-sensing
TLRs in MCMV recognition and the subsequent production of
proinflammatory cytokines and type I IFN by splenic pDCs
[19,31,33,44]. Production of type I IFN is a critical early step in
antiviral defense, and we further demonstrated diminished levels of
liver IFN-a in MCMV-infected 3d mice. This defect was in part
due to an impaired ability of liver pDCs to express this cytokine
and is consistent with previous reports identifying pDCs as an
important early source of IFN-a in response to TLR7 and TLR9
ligands [10,20,31,32,33,45–47]. Altogether, these results concur
with previous studies indicating that pDCs are the predominant
leukocyte producer of type I IFN in the liver during early MCMV
infection [20], and demonstrate that production of these cytokines
by pDCs is influenced by the 3d mutation.
Despite impairments in liver IFN-a production in 3d mice, it is
notable that this response was not totally abrogated. This suggests
the presence of alternative pathways to type I IFN production in
the liver, and may be the reason that IFNa/bR-deficient mice die
by day 5 in response to infection with a moderate dose of MCMV,
as reported previously [36], while 3d mice do not. Studies have
also demonstrated production of type I interferon from cells other
than pDCs at 44–48 hours following MCMV infection [32,48,49].
In addition, the liver contains a variety of parenchymal and non-
parenchymal cells that express TLRs and are capable of type I
IFN production [38,40–42]. There may also be TLR-independent
pathways leading to the production of these cytokines in response
to MCMV, including cytoplasmic RNA- and DNA-sensing
receptors, as have been demonstrated with other virus models
but have yet to be examined in the context of MCMV infection
[1–4,50–55].
It has been established that NK cell inflammatory responses and
production of IFN-c are essential to defense against MCMV in the
liver [23–25]. In 3d mice, NK cell production of IFN-c in the liver
was severely impaired during early MCMV infection and likely
contributed to increased viral burden and liver pathology. The
reduced levels of IFN-c in NK cells may reflect the deficiency of
serum IL-12 seen in 3d mice. These results concur with previous
reports that type I IFN regulates IL-12 production by conventional
DCs and consequently the production of IFN-c by NK cells
[19,48,56]. The defect in liver cytokine production in 3d mice is
reminiscent of that reported for MyD88-deficient mice. Notably,
however, MyD88-deficient mice exhibited more severe liver
pathology and greater elevations in viral titers when compared
to WT than we observed in 3d mice [20]. Interestingly, mice
deficient in TLR7 and TLR9 exhibited decreased levels of
systemic IFN-a/b and increased susceptibility to MCMV infection
Table 1. Quantitation of liver inflammatory foci and cell infiltrates in WT and 3d mice during MCMV infection.
No. Foci per 50 mm
2a No. Nucleated cells per focus
a
Strain Day 0 Day 3 Day 5 Day 7 Day 0 Day 3 Day 5 Day 7
WT ,14 0 616 32688 6804 4 612 59612 2763
3d ,14 0 68 112624
b 24616 0 4562 .60
c 3666
aData presented represent the mean 6 SD of two liver sections unless otherwise indicated.
bNumber of foci per 8650 mm
2 areas in day 5 infected 3d livers was significantly higher than WT at the same infection time point, p#0.04.
CNucleated cells from large areas of inflammation contained .60 nucleated cells in less defined foci, and do not include a calculation of SD.
doi:10.1371/journal.pone.0039161.t001
Figure 5. Assessment of virus-induced liver disease in 3d mice.
Serum samples were collected from C57BL/6 (WT) or 3d mice that were
either uninfected or infected for 3, 5, or 7 days with MCMV. Circulating
levels of ALT were measured as described in Methods. Data are the
combined results from three independent experiments and show the
mean 6 SD (n=6–8 mice per group). Asterisks denote p values#0.003.
doi:10.1371/journal.pone.0039161.g005
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notion that the liver possesses compensatory mechanisms to
combat viral infection in the combined absence of endosomal
TLR signals.
Accordingly, despite the early effects of endosomal TLR
deficiency, 3d mice were able to mount robust CD8+ T cell
cytokine responses. It should be noted that the 3d defect has
previously been shown to impair exogenous antigen presentation,
including cross presentation, which has a reported role in priming
CD8+ T cell responses during MCMV infection [35]. However,
we detected no overt defect in CD8+ T cell responses within the
first seven days of MCMV infection in the liver. Further,
examination of activation markers suggested that a similar pro-
portion of CD8+ T cells from 3d mice were more highly activated
when compared to WT (data not shown). Several studies have
demonstrated the contribution of activated virus-specific CD8+ T
cells to effective hepatic immunity against MCMV infection [26–
28]. In addition, the normal development of adaptive responses
despite impaired innate responses is well documented during
MCMV infection. Studies have shown that reduced levels of type I
IFN do not affect the accumulation or activation of antigen-
specific CD8+ T cells in response to low or moderate MCMV
inoculums [48]. Likewise, while IL-12 is critical in inducing NK
cell IFN-c expression, T cell responses can occur in an IL-12-
independent manner [17,18,57–59]. NK cells have the potential to
negatively regulate CD8+ T cell responses during MCMV
infection [60–62]; thus, it is probable that impaired NK cell
function in the absence of endosomal TLR signals contributes to
inflated T cell responses. The presence of increased virus in the
liver may also contribute to the robust T cell recruitment and
cytokine production observed at late infection time points in 3d
mice. Interestingly, although the severity of viral liver pathology
was more pronounced in 3d mice, inflammation and liver injury
subsided late in infection. These observations suggest that CD8+ T
cells in the liver can respond to limited amounts of type I
interferon for activation in the presence of compromised innate
responses, emphasizing the prevalence of compensatory mechan-
isms in place within the liver to deal with infection and promote
adaptive immunity. In contrast, IFN-a/bR deficiency negatively
impacts innate inflammatory responses and resistance to MCMV
infection in the liver [21,24,36].
In conclusion, this study indicates that UNC93B1, which is
essential for combined endosomal TLR signaling, contributes to
development of effective innate immune responses to an acute
Figure 6. Effect of the 3d mutation on viral clearance. Livers were harvested from C57BL/6 (WT) or 3d mice that were either uninfected or
infected for 3, 5, 7 or 9 days with MCMV (5610
4 PFU). Viral titers were determined using a standard plaque assay. The level of detection of the plaque
assay is 2 log PFU/g liver (dashed line). Each data point represents an individual WT (filled diamonds) or 3d mouse (open circles). Data from days 0, 3,
5, and 7 are the combined results of three independent experiments (n=4–7 mice per group). In data from day 9, n=5 mice per group. Asterisks
denote a significant difference between WT and 3d mean PFU/g liver (p values#0.04).
doi:10.1371/journal.pone.0039161.g006
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involves modulation of early innate proinflammatory cytokine
production from liver pDCs and NK cells and subsequent control
of MCMV replication and pathology before activation of an
adaptive immune response. Altogether, these results highlight
a process of virus recognition with multiple pathways in place to
promote host resistance to infection in the liver microenvironment.
Methods
Mice
Pathogen-free C57BL/6J mice were obtained from the Jackson
Laboratory (Bar Harbor, ME). C57BL/6 Unc93b1
3d/3d mice were
a kind gift from Dr. Bruce Beutler (The Scripps Research Institute,
La Jolla, CA) and were generated as described [35]. C57BL/6J
mice were housed and UNC93b1
3d/3d mice were bred in pathogen-
free mouse facilities at Brown University. Male and female mice
aged 8–10 weeks were used in experiments. This study was carried
out in strict accordance with the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National
Institutes of Health. All animal work was approved by the Brown
University Institutional Animal Care and Use Committee (Pro-
tocol Number: 0909082 and 0903035).
Virus Infection and viral titer determination
MCMV Smith strain was used in all experiments. This strain
was prepared as a salivary gland-passaged stock from CD1 mice.
Moderate dose infection (5610
4 PFU per mouse) was initiated on
day 0 by intraperitoneal injection. In vivo responses were
measured at indicated time points. For infectious viral titer
quantification, organs were weighed, homogenized in cold
supplemented DMEM (Invitrogen Life Technologies) and super-
natants were collected following centrifugation. Serially diluted
samples were used to inoculate confluent monolayers of bone
marrow stromal cells (ATCC M2-10B4) in 24-well tissue culture
plates and incubated for one hour at 37uC, 5% CO2. Following
incubation, inoculums were removed and monolayers were
overlaid with a 16DMEM/0.5% low-melt agarose solution. Cells
were incubated for 7 days at 37uC, 5% CO2, then fixed in 10%
buffered formalin and stained with crystal violet. Plaques were
counted to determine viral titer as previously described [22,24,26].
Sample preparation
Liver leukocytes were prepared as previously described [23–25].
Briefly, following mechanical dissociation of tissue, red blood cells
were removed by lysis with ammonium chloride and leukocytes
separated by Percoll density gradient. To generate homogenates
for cytokine analysis, the liver caudate lobe was homogenized in
RPMI 1640 (Invitrogen Life Technologies) and supernatants
collected following centrifugation. Serum was isolated from whole
blood by centrifugation in the presence of heparin and stored at
280uC until further use in cytokine analyses or ALT assays.
Cytokine analysis
Liver homogenates and serum were tested for cytokines by
standard sandwich ELISA. IFN-c, IL-12p70 and TNF-a were
assayed by DuoSet (R&D Systems). IFN-a was measured by
VeriKine mouse ELISA kit (R&D Systems). Limits of detection
were 15 pg/mL for DuoSets and 12.5 pg/mL for VeriKine
ELISA kits.
Flow cytometric analysis
The following fluorochrome-conjugated mAbs were used in
flow cytometric analyses: NK1.1-PE and TCRb-APC to distin-
guish NK cells; CD8a-PECy7 and TCRb-FITC to distinguish
CD8+ T cells; and PDCA-1-APC (Miltenyi Biotec) to identify
pDCs. Prior to surface staining, cells were incubated with anti-
CD16/CD32 mAb to block nonspecific binding of Abs to Fcc III/
II receptors (clone 2.4G2). Unless otherwise noted, antibodies were
obtained from BD Biosciences or eBioscience. For intracellular
staining of cytokines, cells were treated with Brefeldin A
(eBioscience) for 4 hours at 37uC, 5% CO2 and permeabilized
prior to labeling with IFN-a-FITC (R&D Systems), IFN-c-PE, or
TNF-a-APC (BD Biosciences). When indicated, leukocytes were
stimulated for 5 hours with 100 ng/mL MCMV M45 peptide in
addition to Brefeldin A treatment. Samples were acquired using
a FACSCalibur and analyzed with BD Cell Quest software. For
analysis, viable cells were gated by FSC and SSC. Isotype controls
were used to set positive analysis gates.
Liver histology and serum ALT analysis
Portions of the median liver lobes were isolated, fixed in 10%
neutral buffered formalin, and paraffin embedded. Tissue sections
(5 mm) were stained with H&E and analyzed microscopically.
Images shown were photographed at the indicated magnification
with a DP70 digital camera and software (Optical Analysis
Corporation). Inflammatory foci, defined as discrete clusters
containing between 6–60 nucleated cells, were quantitated as
described previously [23]. In brief, inflammatory foci were
identified, at a magnification of 200, as clusters of cells in totals
of 8650 mm
2 areas per representative tissue. In some cases, liver
sections had larger areas of inflammation with .60 cells with less
defined foci, and are indicated as such. Numbers of nucleated cells
per inflammatory foci were counted in 20 individual foci per
representative tissue at a magnification of 400. Liver alanine
aminotransferase (ALT) was measured in serum samples by
Marshfield Labs (Marshfield, WI).
Statistical analysis
Student’s t test was used to determine statistical significance of
experimental results when indicated (p#0.05).
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